Impact of anaemia and iron deficiency on outcomes in cardiogenic shock complicating acute myocardial infarction
ConclusionConcomitant anaemia without ID presence in patients with CS at hospital presentation is associated with higher risk for death from any cause or renal replacement therapy and the individual components of this composite endpoint within 30 days after hospitalization. ID has no relevant impact on clinical outcomes in patients with CS. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - January 2, 2024 Category: Cardiology Authors: Danilo Obradovic,
Goran Loncar,
Uwe Zeymer,
Janine P öss,
Hans‐Josef Feistritzer,
Anne Freund,
Alexander Jobs,
Georg Fuernau,
Steffen Desch,
Uta Ceglarek,
Berend Isermann,
Stephan von Haehling,
Stefan D. Anker,
Petra Büttner,
Holger Thie Tags: Research Article Source Type: research
Growth differentiation factor ‐15 in sodium–glucose cotransporter 2 inhibition: Mechanistic insights from the EMPEROR program
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - January 2, 2024 Category: Cardiology Authors: Hatim Seoudy,
Jakob Christoph Voran,
Derk Frank Tags: Invited Editorial Source Type: research
Letter regarding the article ‘Head‐to‐head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines’
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - January 2, 2024 Category: Cardiology Authors: Laiba Amini,
Samia Kazmi,
Muhammad Junaid Patel Tags: Letter to the Editor Source Type: research
Impact of Clinical Phenogroup Diversity and Multiplicity: Impact on Mechanisms of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction
ConclusionsThough cardiac output response to exercise is limited in patients with HFpEF compared to those with non-cardiac dyspnea, the relative contributions of cardiac and peripheral limitations vary with differing numbers and types of clinical phenotypic traits present. Patients fulfilling criteria for greater multiplicity and diversity of HFpEF phenogroup traits have poorer exercise capacity, worsening hemodynamic perturbations, and greater risk for adverse outcome.This article is protected by copyright. All rights reserved. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 30, 2023 Category: Cardiology Authors: Kathryn Larson,
Massar Omar,
Hidemi Sorimachi,
Kazunori Omote,
Alessio Alogna,
Dejana Popovic,
Atsushi Tada,
Shunichi Doi,
Jwan Naser,
Yogesh N.V. Reddy,
Margaret M. Redfield,
Barry A. Borlaug Tags: Research Article Source Type: research
Exercise catheterization in adults post ‐Fontan with normal and abnormal hemodynamic criteria: insights into normal Fontan physiology
ConclusionPAWP>20 mmHg and mean PA pressure > 25 mmHg could be used to define elevated values during exercise in adults post-Fontan. The major discrepancy in exercise hemodynamics among Group II compared to controls appears to be the degree of systemic venous hypertension and arterial desaturation.This article is protected by copyright. All rights reserved. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 29, 2023 Category: Cardiology Authors: William R. Miranda,
C. Charles Jain,
Barry A. Borlaug,
Heidi M. Connolly,
Luke J. Burchill,
Alexander Van De Bruaene,
Alexander C. Egbe Tags: Research Article Source Type: research
Vasodilators in congestive heart failure: The perfect weapon aiming just off the target? Letter regarding the article ‘Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS‐986231)’
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 29, 2023 Category: Cardiology Authors: Pier Paolo Bocchino,
Guglielmo Gallone,
Simone Frea,
Gaetano Maria De Ferrari Tags: Letter to the Editor Source Type: research
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials
ConclusionOur observations are consistent with experimental observations that empagliflozin down-regulates profibrotic signalling. The importance of such an effect for the clinical benefits of SGLT2i in HF remains to be elucidated. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 29, 2023 Category: Cardiology Authors: Jo ão Pedro Ferreira,
Javed Butler,
Stefan D. Anker,
James L. Januzzi,
Marina Panova‐Noeva,
Alexander L. Reese‐Petersen,
Naveed Sattar,
Elke Schueler,
Stuart J. Pocock,
Gerasimos Filippatos,
Milton Packer,
Mikhail Sumin,
Faiez Zannad,
EM Tags: Research Article Source Type: research
Artificial Intelligence methods for Improved Detection of undiagnosed Heart Failure with Preserved Ejection Fraction (HFpEF)
ConclusionsThis study demonstrates that patients with undiagnosed HFpEF are an at-risk group with high mortality. It is possible to use NLP methods to identify likely HFpEF patients from EHR data who would likely then benefit from expert clinical review and complement the use of diagnostic algorithms.This article is protected by copyright. All rights reserved. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 28, 2023 Category: Cardiology Authors: Jack Wu,
Dhruva Biswas,
Matthew Ryan,
Brett Bernstein,
Maleeha Rizvi,
Natalie Fairhurst,
George Kaye,
Ranu Baral,
Tom Searle,
Narbeh Melikian,
Daniel Sado,
Thomas F L üscher,
Richard Grocott‐Mason,
Gerald Carr‐White,
James Teo,
Richard Tags: Research Article Source Type: research
Cardiorespiratory Fitness and Risk of Heart Failure with Preserved Ejection Fraction
Conclusions and RelevanceHigher CRF levels are independently associated with lower HRpEF in a dose-response manner. Changes in CRF reflected proportional changes in HFpEF risk, suggesting that the HFpEF risk was modulated by CRF.This article is protected by copyright. All rights reserved. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 28, 2023 Category: Cardiology Authors: Peter Kokkinos,
Charles Faselis,
Andreas Pittaras,
Immanuel Babu Henry Samuel,
Carl J. Lavie,
Jose D. Vargas,
Michael Lamonte,
Barry Franklin,
Themistocles L. Assimes,
Rayelynn Murphy,
Jiajia Zhang,
Xuemei Sui,
Jonathan Myers Tags: Research Article Source Type: research
Letter Regarding the Article, “Head‐to‐Head Comparison Between Recommendations by the ESC and ACC/AHA/HFSA Heart Failure Guidelines”1
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 28, 2023 Category: Cardiology Authors: By
Laiba Amini,
Samia Kazmi,
Muhammad Junaid Patel Tags: Letter to Editor Source Type: research
Real ‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population
ConclusionsRW HOCM patients differ from the EXPLORER-HCM population for their older age, lower LVEF and larger atrial volume, potentially reflecting a more advanced stage of the disease. About half of RW HOCM patients were found eligible to mavacamten.This article is protected by copyright. All rights reserved. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 23, 2023 Category: Cardiology Authors: Edoardo Bertero,
Chiara Chiti,
Maria Alessandra Schiavo,
Giacomo Tini,
Paolo Costa,
Giancarlo Todiere,
Barbara Mabritto,
Lorenzo ‐Lupo Dei,
Alessia Giannattasio,
Davide Mariani,
Carla Lofiego,
Caterina Santolamazza,
Emanuele Monda,
Giovanni Tags: Short Report Source Type: research
Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR ‐TIMI 53, DECLARE‐TIMI 58 and CAMELLIA‐TIMI 61
ConclusionsThe risk of HHF varies across BMI categories for any given range of circulating NT-proBNP. These findings showcase the importance of considering BMI when applying NT-proBNP for HF risk stratification, particularly for patients with low-level elevations in NT-proBNP (125-<450 pg/mL) where there appears to be a clinically meaningful absolute and relative risk gradient.This article is protected by copyright. All rights reserved. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 22, 2023 Category: Cardiology Authors: Siddharth M. Patel,
David A. Morrow,
Andrea Bellavia,
David D. Berg,
Deepak L. Bhatt,
Petr Jarolim,
Lawrence A. Leiter,
Darren K. McGuire,
Itamar Raz,
P. Gabriel Steg,
John P. H. Wilding,
Marc S. Sabatine,
Stephen D. Wiviott,
Eugene Braunwald Tags: Research Article Source Type: research
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: data from the Swedish Heart Failure Registry
ConclusionThe burden of both CV and non-CV comorbidities was high in HF regardless of EF, but overall higher in HFpEF. Multimorbidity was associated with a high risk of death with a different burden on CV or non-CV outcomes.This article is protected by copyright. All rights reserved. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 22, 2023 Category: Cardiology Authors: Daniela Tomasoni,
Cristiana Vitale,
Federica Guidetti,
Lina Benson,
Frieder Braunschweig,
Ulf Dahlstr öm,
Michael Melin,
Giuseppe M C Rosano,
Lars H Lund,
Marco Metra,
Gianluigi Savarese Tags: Research Article Source Type: research
Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right ‐Sided Heart Failure and Tricuspid Regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
This article is protected by copyright. All rights reserved. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 22, 2023 Category: Cardiology Authors: Marianna Adamo,
Ovidiu Chioncel,
Matteo Pagnesi,
Antoni Bayes ‐Genis,
Magdy Abdelhamid,
Stefan D. Anker,
Elena‐Laura Antohi,
Luigi Badano,
Tuvia Ben Gal,
Michael Böhm,
Victoria Delgado,
Julien Dreyfus,
Francesco F. Faletra,
Dimitrios Far Tags: Position Paper Source Type: research
Association of neighbourhood ‐level material deprivation with adverse outcomes and processes of care among patients with heart failure in a single‐payer healthcare system: A population‐based cohort study
ConclusionPatients with newly-diagnosed heart failure residing in the most deprived neighbourhoods had worse outcomes and reduced access to care than those less deprived. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - December 21, 2023 Category: Cardiology Authors: David Bobrowski,
Andrew Dorovenis,
Husam Abdel ‐Qadir,
Candace D. McNaughton,
Rea Alonzo,
Jiming Fang,
Peter C. Austin,
Jacob A. Udell,
Cynthia A. Jackevicius,
David A. Alter,
Clare L. Atzema,
R. Sacha Bhatia,
Gillian L. Booth,
Andrew C.T. Tags: Research Article Source Type: research
